FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

426320005: Primaquine phosphate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2661571012 Primaquine phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2675152014 Primaquine phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Primaquine phosphate (substance) Is a Primaquine false Inferred relationship Some
Primaquine phosphate (substance) Is a Primaquine (substance) false Inferred relationship Some
Primaquine phosphate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Primaquine (substance) true Inferred relationship Some
Primaquine phosphate (substance) Is a Aminoquinoline antimalarial true Inferred relationship Some
Primaquine phosphate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antimalarial (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely primaquine phosphate 15 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Primaquine phosphate (substance) Inferred relationship Some
Product containing precisely primaquine (as primaquine phosphate) 26.3 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Primaquine phosphate (substance) Inferred relationship Some
Product containing precisely primaquine (as primaquine phosphate) 26.3 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Primaquine phosphate (substance) Inferred relationship Some 1
Product containing precisely primaquine phosphate 15 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Primaquine phosphate (substance) Inferred relationship Some 1
Product containing precisely primaquine phosphate 15 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Primaquine phosphate (substance) Inferred relationship Some 1
Product containing precisely primaquine phosphate 15 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Primaquine phosphate (substance) Inferred relationship Some 1
Product containing precisely primaquine (as primaquine phosphate) 26.3 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Primaquine phosphate (substance) Inferred relationship Some 1
Primaquine (as primaquine phosphate) 7.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Primaquine phosphate (substance) Inferred relationship Some 1
Product containing precisely primaquine (as primaquine phosphate) 15 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Primaquine phosphate (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start